Clinical Trial

Intravenous Tramadol and Magnesium Sulphate for Prevention of Shivering

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated September 25, 2024 (before its estimated January 10, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this work was to compare the efficacy of intravenous (IV) tramadol versus magnesium sulphate added to 100 ml saline for prevention of shivering associated with spinal anesthesia.
Trial Details
NCT Number NCT06612996
Lead Sponsor Al-Azhar University
Conditions Lower Extremity Chronic Venous Ulcers, Varicose Veins Leg, Hernia
Enrollment 180 participants
Start Date 2024-10-10
Primary Completion 2025-01-10 (estimated)
Study Completion 2025-01-10 (estimated)
Updated on ClinicalTrials.gov 2024-09-25